Health Ministry Decides Against Including Itolizumab In Clinical Management Protocols For COVID-19
The National Task Force on COVID-19 has decided against including Itolizumab drug in clinical management protocols for treating the disease. Biocon’s Itolizumab is an approved drug which is used for…
Share